These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 35022525
1. MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data. Rana S, Valbuena GN, Curry E, Bevan CL, Keun HC. Br J Cancer; 2022 Feb; 126(3):502-513. PubMed ID: 35022525 [Abstract] [Full Text] [Related]
7. Biomarker Potential of Plasma MicroRNA-150-5p in Prostate Cancer. Paunescu IA, Bardan R, Marcu A, Nitusca D, Dema A, Negru S, Balacescu O, Balacescu L, Cumpanas A, Sirbu IO, Petrut B, Seclaman E, Marian C. Medicina (Kaunas); 2019 Sep 03; 55(9):. PubMed ID: 31484346 [Abstract] [Full Text] [Related]
8. A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine. Fredsøe J, Rasmussen AKI, Mouritzen P, Borre M, Ørntoft T, Sørensen KD. Int J Cancer; 2019 Nov 01; 145(9):2558-2567. PubMed ID: 30903800 [Abstract] [Full Text] [Related]
9. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role. Cochetti G, Poli G, Guelfi G, Boni A, Egidi MG, Mearini E. Onco Targets Ther; 2016 Nov 01; 9():7545-7553. PubMed ID: 28008272 [Abstract] [Full Text] [Related]
10. Clinical significance of miRNA host gene promoter methylation in prostate cancer. Daniunaite K, Dubikaityte M, Gibas P, Bakavicius A, Rimantas Lazutka J, Ulys A, Jankevicius F, Jarmalaite S. Hum Mol Genet; 2017 Jul 01; 26(13):2451-2461. PubMed ID: 28398479 [Abstract] [Full Text] [Related]
11. Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort. Chiorino G, Petracci E, Sehovic E, Gregnanin I, Camussi E, Mello-Grand M, Ostano P, Riggi E, Vergini V, Russo A, Berrino E, Ortale A, Garena F, Venesio T, Gallo F, Favettini E, Frigerio A, Matullo G, Segnan N, Giordano L. Sci Rep; 2023 Jul 25; 13(1):12040. PubMed ID: 37491482 [Abstract] [Full Text] [Related]
14. Correlations between serum levels of microRNA-148a-3p and microRNA-485-5p and the progression and recurrence of prostate cancer. He W, Zhang F, Jiang F, Liu H, Wang G. BMC Urol; 2022 Nov 25; 22(1):195. PubMed ID: 36434610 [Abstract] [Full Text] [Related]
15. Diagnostic and prognostic micro-RNAs in ischaemic stroke due to carotid artery stenosis and in acute coronary syndrome: a four-year prospective study. Gacoń J, Badacz R, Stępień E, Karch I, Enguita FJ, Żmudka K, Przewłocki T, Kabłak-Ziembicka A. Kardiol Pol; 2018 Nov 25; 76(2):362-369. PubMed ID: 29350392 [Abstract] [Full Text] [Related]
16. Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients. Ramirez-Garrastacho M, Berge V, Linē A, Llorente A. Br J Cancer; 2022 Feb 25; 126(3):492-501. PubMed ID: 34811506 [Abstract] [Full Text] [Related]
19. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer. Sun X, Yang Z, Zhang Y, He J, Wang F, Su P, Han J, Song Z, Fei Y. Int J Clin Exp Pathol; 2015 Feb 25; 8(7):8394-401. PubMed ID: 26339409 [Abstract] [Full Text] [Related]